Genalyte Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 96

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 22

Genalyte General Information

Description

Developer of a diagnostic testing system designed to deliver rapidly deployable mobile laboratories with real-time diagnostics anywhere in the delivery system. The company performs the majority of tests in any healthcare setting with a rapidly deployable mobile laboratory in under thirty minutes, and the central lab handles tests that cannot be performed on-site, enabling physicians to improve the quality of care for patients and reduce resource utilization across the healthcare system.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10520 Wateridge Circle
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 10520 Wateridge Circle
  • San Diego, CA 92121
  • United States
+1 (858)

Genalyte Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genalyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private Completed Generating Revenue
10. Accelerator/Incubator 06-Jun-2025 Completed Generating Revenue
9. Later Stage VC (Series C) 29-Oct-2024 Completed Generating Revenue
8. Later Stage VC (Series C2) 06-Mar-2023 Completed Generating Revenue
7. Later Stage VC (Series C1) 11-Jan-2021 Completed Generating Revenue
6. Later Stage VC 15-Apr-2020 Completed Generating Revenue
5. Later Stage VC 21-Nov-2016 Completed Generating Revenue
4. Later Stage VC (Series C) 18-Aug-2015 Completed Generating Revenue
3. Grant 18-Oct-2013 $1M $15.9M Completed Generating Revenue
2. Later Stage VC (Series B) 30-Mar-2012 $11.9M $15.9M Completed Startup
To view Genalyte’s complete valuation and funding history, request access »

Genalyte Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C2
Series C1
Series C 166,775,414 $0.000100 $0.06 $1 $1 1x $1 52.42%
Series A2 1,634,785 $0.000100 $0.6 $10 $10 1x $10 0.51%
To view Genalyte’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Genalyte Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diagnostic testing system designed to deliver rapidly deployable mobile laboratories with real-time diagn
Diagnostic Equipment
San Diego, CA
96 As of 2026

Toronto, Canada
 

Nehren, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genalyte Competitors (16)

One of Genalyte’s 16 competitors is SQI Diagnostics, a Corporation company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SQI Diagnostics Corporation Toronto, Canada
Hain Lifescience Corporate Backed or Acquired Nehren, Germany
BioGenex Laboratories Corporation Fremont, CA
PixCell Medical Technologies Formerly VC-backed Yokneam Ilit, Israel
DiaSys Diagnostic Systems Corporate Backed or Acquired Holzheim, Germany
You’re viewing 5 of 16 competitors. Get the full list »

Genalyte Patents

Genalyte Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4747641-A1 Automated laboratory system, and cloud laboratory system Pending 18-Jul-2023
WO-2025019638-A1 Automated laboratory system, and cloud laboratory system Inactive 18-Jul-2023
EP-4127714-A1 Rapid multiplexed serological test Pending 02-Apr-2020
EP-4127714-A4 Rapid multiplexed serological test Pending 02-Apr-2020
US-20210396755-A1 Rapid multiplexed serological test Pending 02-Apr-2020 G01N33/56983
To view Genalyte’s complete patent history, request access »

Genalyte Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genalyte Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
IPD Capital Venture Capital Minority
MedTech Innovator Accelerator/Incubator
Parade Ventures Venture Capital Minority
Seed Healthcare Venture Capital Minority
Boutique Venture Partners Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

Genalyte Acquisitions (1)

Genalyte’s most recent deal was a Merger/Acquisition with BaseHealth. The deal was made on 12-Mar-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BaseHealth 12-Mar-2020 Merger/Acquisition Decision/Risk Analysis
To view Genalyte’s complete acquisitions history, request access »

Genalyte FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process